<< Back
EDN [EPX] (IDK® EDN), ELISA
K6811, 6811
Article number:
K 6811
Tests:
96 Tests
Incubation time:
1h; 1h; 10-20min
Volume:
20 µl
Matrix:
Serum, Urine, Plasma, Stool (15 mg)
Standards:
0.25-16 ng/ml
Method:
ELISA
Details (PDF)
To access these files, you need the Acrobat Reader
EDN (eosinophil-derived neurotoxin, eosinophil protein x, EPX), a cationic glycoprotein, which is released by activated eosinophiles, has strong cytotoxic characteristics and plays a significant role in the prevention of virus infections. It is released by the eosinophile granules in places where eosinophiles are mainly found, in the skin, lungs, urogenital, gastrointestinal tract, that is, in the organs which act as an entry point for pathogens. The accumulation of EDN in the intestine is associated with tissue damage.
Measuring EDN in stool can serve as an objective parameter for a current clinical or sub-clinical cronic inflammation which is located in the gastrointestinal area. In the case of Colitis ulcerosa and Crohn’s disease, the EDN measurement enables the evaluation of a disease’s activity and the prediction of a relapse.

Also available as 1-point-calibration assay (K 6821)


Purchase Order Processing

Claudia Wandesleben / Gudrun Gutschalk
Phone: +49 (0)6251 - 70190-175 /-177
Fax: +49 (0)6251 - 84 94 30
Email: export@immundiagnostik.com

Contact Form Order Form